Repositorio Institucional
Repositorio Institucional
CONICET Digital
  • Inicio
  • EXPLORAR
    • AUTORES
    • DISCIPLINAS
    • COMUNIDADES
  • Estadísticas
  • Novedades
    • Noticias
    • Boletines
  • Ayuda
    • General
    • Datos de investigación
  • Acerca de
    • CONICET Digital
    • Equipo
    • Red Federal
  • Contacto
JavaScript is disabled for your browser. Some features of this site may not work without it.
  • INFORMACIÓN GENERAL
  • RESUMEN
  • ESTADISTICAS
 
Artículo

Pathophysiological role of histamine H4 Receptor in cancer: therapeutic implications

Nicoud, Melisa BeatrizIcon ; Formoso, KarinaIcon ; Medina, Vanina AraceliIcon
Fecha de publicación: 05/2019
Editorial: Frontiers Media S.A.
Revista: Frontiers in Pharmacology
ISSN: 1663-9812
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:
Oncología

Resumen

Cancer is a leading cause of death in both developed and developing countries. Although advances in cancer research lead to improved anti-neoplastic therapies, they continue to have unfavorable outcomes, including poor response and severe toxicity. Thus, the challenge for the new therapeutic approaches is to increase anti-tumor efficacy by targeting different molecules encompassed in the tumor and its microenvironment, as well as their specific interactions. The histamine H4 receptor (H4R) is the last discovered histamine receptor subtype and it modulates important immune functions in innate and in adaptive immune responses. Several ligands have been developed and some of them are being used in clinical trials for immune disorders with promising results. When searched in The Cancer Genome Atlas (TCGA) database, human H4R gene was found to be expressed in bladder cancer, kidney cancer, breast cancer, gastrointestinal cancers, lung cancer, endometrial cancer, and skin cancer. In the present work, we aimed to briefly summarize current knowledge in H4R's pharmacology and in the clinical use of H4R ligands before focusing on recent data reporting the expression of H4R and its pathophysiological role in cancer, representing a potential molecular target for cancer therapeutics. H4R gene and protein expression in different types of cancers compared with normal tissue as well as its relationship with patient prognosis in terms of survival will be described.
Palabras clave: ANTICANCER TREATMENT , BLADDER CANCER , BREAST CANCER , GASTROINTESTINAL CANCER , HISTAMINE H4 RECEPTOR , LUNG CANCER , MELANOMA
Ver el registro completo
 
Archivos asociados
Thumbnail
 
Tamaño: 7.914Mb
Formato: PDF
.
Descargar
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution 2.5 Unported (CC BY 2.5)
Identificadores
URI: http://hdl.handle.net/11336/120818
URL: https://www.frontiersin.org/articles/10.3389/fphar.2019.00556/full
DOI: http://dx.doi.org/10.3389/fphar.2019.00556
Colecciones
Articulos(BIOMED)
Articulos de INSTITUTO DE INVESTIGACIONES BIOMEDICAS
Citación
Nicoud, Melisa Beatriz; Formoso, Karina; Medina, Vanina Araceli; Pathophysiological role of histamine H4 Receptor in cancer: therapeutic implications; Frontiers Media S.A.; Frontiers in Pharmacology; 10; 5-2019; 1-15
Compartir
Altmétricas
 

Items relacionados

Mostrando titulos relacionados por título, autor y tema.

  • Artículo Rat ventral prostate xanthine oxidase bioactivation of ethanol to acetaldehyde and 1-hydroxyethyl free radicals: Analysis of its potential role in heavy alcohol drinking tumor-promoting effects
    Castro, Gerardo Daniel ; Delgado, Aurora Maria ; Costantini, Martin Hernan; Castro, Jose Alberto (Wiley-liss, Inc, 2001-02)
  • Artículo Cytosolic xanthine oxidoreductase mediated bioactivation of ethanol to acetaldehyde and free radicals in rat breast tissue. Its potential role in alcohol-promoted mammary cancer
    Castro, Gerardo Daniel ; Delgado, Aurora Maria ; Costantini, Martin Hernan; Castro, Jose Alberto (Elsevier Ireland, 2001-03)
  • Artículo HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity
    Prince, Thomas L.; Lang, Benjamin J.; Guerrero Gimenez, Martin Eduardo ; Fernandez Muñoz, Juan Manuel ; Ackerman, Andrew; Calderwood, Stuart K. (MDPI, 2020-04)
Enviar por e-mail
Separar cada destinatario (hasta 5) con punto y coma.
  • Facebook
  • X Conicet Digital
  • Instagram
  • YouTube
  • Sound Cloud
  • LinkedIn

Los contenidos del CONICET están licenciados bajo Creative Commons Reconocimiento 2.5 Argentina License

https://www.conicet.gov.ar/ - CONICET

Inicio

Explorar

  • Autores
  • Disciplinas
  • Comunidades

Estadísticas

Novedades

  • Noticias
  • Boletines

Ayuda

Acerca de

  • CONICET Digital
  • Equipo
  • Red Federal

Contacto

Godoy Cruz 2290 (C1425FQB) CABA – República Argentina – Tel: +5411 4899-5400 repositorio@conicet.gov.ar
TÉRMINOS Y CONDICIONES